CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Secondary resistances to measles virus (MeV)-based virotherapy
DOI 10.1055/s-0033-1360995
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Berchtold, T Weiland, J Lampe, I Smirnow, S Venturelli, A Berger, J Reiser, F Stubenrauch, NP Malek, M Bitzer, UM Lauer
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Oncolysis has a great potential in treating solid tumors. This is believed to be true also for tumors which have been demonstrated to be resistant to conventional chemotherapy and radiotherapy conclusions. The oncolytic potential of measles vaccine virus (MeV) has been shown both in vitro and in vivo. On the contrary, resistances to MeV-mediated oncolysis were demonstrated to either pre-exist or arise…
Zitieren
Zitierempfehlung
S Berchtold, T Weiland, J Lampe, I Smirnow, S Venturelli, A Berger, J Reiser, F Stubenrauch, NP Malek, M Bitzer, UM Lauer (2014) Secondary resistances to measles virus (MeV)-based virotherapy. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0033-1360995
Mit CareLit weiterarbeiten